Get started
Author

Roberta Facchinetti

Observed names: Facchinetti Roberta, Facchinetti, R, R. Facchinetti
ORCID: 0000-0003-3452-2272
Observed ORCID: 0000-0003-3452-2272
OpenAlex ID: A5079123795
Neuroglia in the autistic brain: evidence from a preclinical model
2018 · Maria Rosanna Bronzuoli, Roberta Facchinetti, et al. · Molecular Autism · 107
PDF
Altered Waste Disposal System in Aging and Alzheimer’s Disease: Focus on Astrocytic Aquaporin-4
2020 · Marta Valenza, Roberta Facchinetti, et al. · Frontiers in Pharmacology · 83
PDF
Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer’s disease by exerting anti-inflammatory and neuroprotective effects
2018 · Caterina Scuderi, Maria Rosanna Bronzuoli, et al. · Translational Psychiatry · 82
PDF
An Animal Model of Alzheimer Disease Based on the Intrahippocampal Injection of Amyloid β-Peptide (1–42)
2017 · Roberta Facchinetti, Maria Rosanna Bronzuoli, et al. · Methods in molecular biology · 66
Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer’s Disease:In VitroandIn VivoEvidence
2018 · Maria Rosanna Bronzuoli, Roberta Facchinetti, et al. · Oxidative Medicine and Cellular Longevity · 60
PDF
Astrocyte Function Is Affected by Aging and Not Alzheimer’s Disease: A Preliminary Investigation in Hippocampi of 3xTg-AD Mice
2019 · Maria Rosanna Bronzuoli, Roberta Facchinetti, et al. · Frontiers in Pharmacology · 49
PDF
Acute Ketamine Facilitates Fear Memory Extinction in a Rat Model of PTSD Along With Restoring Glutamatergic Alterations and Dendritic Atrophy in the Prefrontal Cortex
2022 · Nathalie Sala, Caterina Paoli, et al. · Frontiers in Pharmacology · 39
Looking for a Treatment for the Early Stage of Alzheimer’s Disease: Preclinical Evidence with Co-Ultramicronized Palmitoylethanolamide and Luteolin
2020 · Roberta Facchinetti, Marta Valenza, et al. · International Journal of Molecular Sciences · 38
PDF
Molecular signatures of astrocytes and microglia maladaptive responses to acute stress are rescued by a single administration of ketamine in a rodent model of PTSD
2024 · Marta Valenza, Roberta Facchinetti, et al. · Translational Psychiatry · 29
PDF
Alternative Targets to Fight Alzheimer’s Disease: Focus on Astrocytes
2021 · Marta Valenza, Roberta Facchinetti, et al. · Biomolecules · 24
PDF
Co-Ultramicronized Palmitoylethanolamide/Luteolin Restores Oligodendrocyte Homeostasis via Peroxisome Proliferator-Activated Receptor-α in an In Vitro Model of Alzheimer’s Disease
2022 · Roberta Facchinetti, Marta Valenza, et al. · Biomedicines · 22
PDF
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress
2023 · Tiziana Bonifacino, Jessica Mingardi, et al. · Translational Psychiatry · 20
PDF
Astrocyte: An Innovative Approach for Alzheimer's Disease Therapy
2017 · Maria R. Bronzuoli, Roberta Facchinetti, et al. · Current Pharmaceutical Design · 20
Neuroinflammation in Alzheimer’s Disease: Friend or Foe?
2020 · Caterina Scuderi, Roberta Facchinetti, et al. · The FASEB Journal · 15
Palmitoylethanolamide and White Matter Lesions: Evidence for Therapeutic Implications
2022 · Marta Valenza, Roberta Facchinetti, et al. · Biomolecules · 14
PDF
Sorafenib Chemosensitization by Caryophyllane Sesquiterpenes in Liver, Biliary, and Pancreatic Cancer Cells: The Role of STAT3/ABC Transporter Axis
2022 · Silvia Di Giacomo, Marco Gullì, et al. · Pharmaceutics · 14
PDF
Anti-GluA3 autoantibodies define a new sub-population of frontotemporal lobar degeneration patients with distinct neuropathological features
2024 · Maria Italia, Michela Salvadè, et al. · Brain Behavior and Immunity · 12
Ultramicronized palmitoylethanolamide restores astrocyte-neuron metabolic coupling and Klotho/FGF21 signaling in a triple-transgenic mouse model of Alzheimer’s disease
2026 · Roberta Facchinetti, Marta Valenza, et al. · Biomedicine & Pharmacotherapy · 2
Palmitoylethanolamide and Luteolin in Brain Aging and Cognitive Decline: Biological Rationale and Current Evidence
2026 · Francesca Mancinetti, Virginia Boccardi, et al. · Nutrients
Correction: Neuroglia in the autistic brain: evidence from a preclinical model
2026 · Maria Rosanna Bronzuoli, Roberta Facchinetti, et al. · Molecular Autism
PDF
P18-10 Astrocyte vulnerability to β-amyloid toxicity drives oligodendrocyte dysfunction: insights from in vitro models
2026 · C. Ciarla, R. Facchinetti, et al. · Toxicology Letters
Editorial: Astrocytes and immunity: unveiling their role in pain and neurodegenerative disease progression
2026 · Alessandra Toti, Roberta Facchinetti, et al. · Frontiers in Aging Neuroscience
PDF
Endogenous Activation of mGlu5 Metabotropic Glutamate Receptors Is Required for Oligodendrocyte Maturation and Myelinogenesis in Mice
2026 · Roxana Paula Ginerete, Roberta Facchinetti, et al. · Cells
PDF
Microglial TDP-43 mediates myelin refinement and represses Tyrobp cryptic exon inclusion in mice
2026 · Anne-Claire Compagnion, Andranik Ivanov, et al. · Nature Neuroscience
Ketamine rescues glial reactivity and neuronal changes observed in a new rodent model of resilience/vulnerability to acute stress
2024 · C. Ciarla, R. Facchinetti, et al. · Neuroscience Applied
Works count: 29
Citation count: 695
H-index: 14
I10-index: 17
Year
Topic
Type